secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2025-03-17T23:59:59+00:00
Accession:  0001613103-25-000034
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic principal accounting officer Kirk resigns; Blomquist named successor
------------------------------------------------------------------------------

- Jennifer M. Kirk resigns as Global Controller & Principal Accounting Officer effective May 2, 2025 to become CEO of Exubrion Therapeutics.
- Denise L. Blomquist, Assistant Global Controller, appointed as Global Controller & Principal Accounting Officer effective March 17, 2025.
- Blomquist has 21-year Medtronic tenure; compensation aligns with similar officer positions under MIP, LTIP, and Change in Control Policy.
- Kirk's departure not related to any disagreement over operations, policies, or practices; she will stay through May 2 for transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310325000034/0001613103-25-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310325000034/mdt-20250312.htm
  HTML page:      https://secwatch.observer/filing/0001613103-25-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer